NCT00533585 BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1
NCT00530348 Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One Status COMPLETED Phase PHASE3
NCT00528112 Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study Status COMPLETED Phase PHASE3
NCT00527423 Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD Status COMPLETED Phase PHASE2
NCT00526799 Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00525161 Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer Status TERMINATED Phase PHASE2
NCT00523614 Use of Oral Contraceptives (OCs) Containing Dienogest and Risk of Venous Thromboembolism Status COMPLETED Phase N/A
NCT00522951 SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study Status COMPLETED Phase PHASE3
NCT00522301 Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission Status TERMINATED Phase PHASE2
NCT00516828 Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Status COMPLETED Phase PHASE1/PHASE2
NCT00511797 SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study Status COMPLETED Phase PHASE2/PHASE3
NCT00510250 A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00509795 Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD) Status COMPLETED Phase PHASE3
NCT00506311 Evaluating the Use of Fibrin Tissue Adhesive in Melanoma Patients Status COMPLETED Phase NA